Jungsu Kim

@jungsukim77.bsky.social

Alzheimer, APOE, Actin, Txn factors, Immune, Tau, miRs, Drugs | Single cell & Spatial omics, Proteomics, QTL | ASO, siRNA, AAV | Mouse, iPSC, Drosophila, Zebrafish | Microglia, Astrocytes, Oligodendrocytes https://medicine.iu.edu/faculty/41977/kim-jungsu

Our new review is out today! 𝗧𝗵𝗲 𝗘𝗻𝗲𝗿𝗴𝗲𝘁𝗶𝗰 𝗖𝗼𝗹𝗹𝗮𝗽𝘀𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗕𝗿𝗮𝗶𝗻: 𝗠𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰 𝗜𝗻𝗳𝗹𝗲𝘅𝗶𝗯𝗶𝗹𝗶𝘁𝘆 𝗔𝗰𝗿𝗼𝘀𝘀 𝗖𝗲𝗹𝗹𝘀 𝗮𝗻𝗱 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝘀 We argue that Alzheimer’s disease is not just a problem of brain hypometabolism, but a disorder of metabolic inflexibility. onlinelibrary.wiley.com/doi/10.1111/...

The Energetic Collapse of the Alzheimer's Brain: Metabolic Inflexibility Across Cells and Networks

Metabolic inflexibility in Alzheimer's disease. Schematic illustrating the biphasic trajectory of metabolic activity relative to canonical Alzheimer's disease (AD) biomarkers. In the presymptomatic p...

onlinelibrary.wiley.com

"But given the growing emphasis on funding in many quarters as the sine qua non of academic achievement, we may reach the point where faculty members' obituaries will read along the lines of, "Professor X didn't leave much of an intellectual legacy, but he/she sure brought in a lot of grant money""

End the unchecked growth of publishing fees and the overreliance on unpaid peer review A proposed NIH policy to limit allowable publication costs is a good start — but more must be done Peer reviewers should be paid for their considerable labor | STAT share.google/YXf4iuUCa9Zp...

End the unchecked growth of publishing fees and the overreliance on unpaid peer review

High publishing costs and a crumbling peer review infrastructure are symptoms of deeper structural issues in research.

share.google

😡 The amount of bureaucratic barriers being thrown up for me to host an URM student from an urban high school and pay her a small stipend so she can afford to take this opportunity is making me absolutely stabby. Barriers to participation in STEM are real and undiminished.

Highly recommend everyone take a look! I especially like "Transcriptomic reprogramming represents a promising strategy for treating complex diseases"😍 Title: Cell-type-directed network-correcting combination therapy for Alzheimer’s disease www.cell.com/cell/fulltex...

Cell-type-directed network-correcting combination therapy for Alzheimer’s disease

A multi-cell-type drug discovery strategy targeting dysregulated gene networks in neurons and glia identified letrozole and irinotecan as a combination therapy that significantly improved memory and r...

cell.com

More than a decade-old story, but it resonates again now. "NIA is in an exceptional predicament. In recent years, it has made big commitments to costly clinical trials and large group projects." www.nature.com/articles/468... The value of top-down big projects needs to be reevaluated, especially now

Funding crisis hits US ageing research - Nature

Shortfalls hamper scientists' efforts to address a predicted epidemic of age-related diseases.

nature.com